Health Care·Health Care Equipment·$45.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.76 | N/A | +4.54% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.76 | N/A | +4.54% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized their commitment to growth and innovation.
Management expressed satisfaction with the EPS performance despite not providing revenue details.
They highlighted ongoing investments in innovation and customer engagement.
IDEXX Labs reported an EPS that exceeded expectations, indicating strong profitability. However, the stock fell by 1.38% following the earnings report, likely due to the lack of revenue information and guidance. Investors may be concerned about the absence of detailed financial metrics to assess future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
THE COCA-COLA CO
Oct 16, 2012